A Comprehensive Review of Etiopathogenesis of Oral Submucous Fibrosis
Sukhjinder Kaur Kalra, Alok A Lathi, Shilpa A Lathi
Citation Information :
Kalra SK, Lathi AA, Lathi SA. A Comprehensive Review of Etiopathogenesis of Oral Submucous Fibrosis. Int J Head Neck Surg 2015; 6 (2):76-79.
Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofac Surg 2011;15(1):15-19.
Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966;22(6):764.
Oral submucous fibrosis: etiology, pathogenesis and future research. Bulletin of the World health organization 1994;72(6):985-996.
Oral submucous fibrosis: a case control study in Chennai South India. J Oral Pathol Med 2004;33(5):274-277.
Oral submucous fibrosis in India: a new epidermic. National Med J India 1998;11(3):113-116.
Oral submucous fibrosis—current concepts in etiopathogenesis. People's journal of scientific research, 2008;6(1):39-44.
Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine, 1998;10(9):713-719.
Betelquid and areca nut chewing and some areca nut derived nitrosoamines. Lyon IARC, 2004;85(1):123-129.
Betel quid without tobacco as a risk factor for oral precancers. Oral Oncology 2004;40(7):697-704.
Role of chewing and smoking habits in the aetiology of oral submucous fibrosis (OSF): a case control study. J Oral Pathol Med 1998;27(10):475-479.
A case-control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut. J Oral Pathol Med 1990;19(2):94-98.
Oral submucous fibrosis: A review. Ann Acad Med Singapore 1989 Sep;18(5):603-607.
Association of CTLA 4 gene polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med 2004;33(4):200-203.
Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med 2004;33(1):1-6.
Oral submucous fibrosis: a new treatment regimen. J Oral Maxillofacial Surg 1988;46(10):830-833.
Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions. Oral Pathol Oral Med Oral Surg Endo 1990;70(4):458-461.
Oral submucous fibrosis Review on aetiology and pathogenesis. Oral Oncology, 2005;42(6):561-568.
Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 1999;28(2):59-63.
Extracellular matrix remodeling in oral submucous fibrosis; its stagespecific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 2005;34(8):498-507.
Fibroblast growth factor enhancing activity of tumour necrosis factor and its relationship to other polypeptide growth factors. J Experiment Med 1986;163(3):632-643.
Molecular pathogenesis of oral submucous fibrosis–collagen metabolic disorder. J Oral Pathol Med 2005;34(6):321-328.
HLA typing in oral submucous fibrosis. Tissue Antigen 1985;26(2):138-142.
Collagen biosynthesis in human OSF fibroblast cultures. J Dent Res 1995;74(11):1783-1788.